Effect of colistin exposure on calcium homeostasis and mitochondria functions in chick cortex neurons

Toxicology Mechanisms and Methods

Volumn 23, Issue 4, 2013, Pages 281-288

  Dai, Chongshan ^a   Zhang, Dexian ^b   Li, Jichang ^a   Li, Jian ^c  

^a NORTHEAST AGRICULTURAL UNIVERSITY   (China)

^b SHENYANG AGRICULTURAL UNIVERSITY   (China)

^c MONASH UNIVERSITY   (Australia)

Author keywords

Calcium homeostasis; Calmodulin; Colistin; in vitro; Mitochondria dysfunction

Indexed keywords

CALCIUM; CALMODULIN; COLISTIN; LACTATE DEHYDROGENASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; AUTOPHAGY; BRAIN CORTEX; CALCIUM HOMEOSTASIS; CELL ACTIVITY; CELL MEMBRANE DEPOLARIZATION; CELL VIABILITY; CONTROLLED STUDY; ENZYME RELEASE; IN VITRO STUDY; IN VIVO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRION; NERVE CELL; NEUROTOXICITY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CALCIUM; CALMODULIN; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CEREBRAL CORTEX; CHICK EMBRYO; COLISTIN; FLOW CYTOMETRY; HOMEOSTASIS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MICROSCOPY, ELECTRON; MITOCHONDRIA; NEURONS; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84879589131     PISSN: 15376516     EISSN: 15376524     Source Type: Journal    
DOI: 10.3109/15376516.2012.754533     Document Type: Article

References (51)

1. Azzopardi EA, Ferguson EL, Thomas DW. (2012). Colistin past and future: a bibliographic analysis. J Crit Care Jul 2 [Epub ahead of print]. doi: 10.1016/j.jcrc.2012.04.008.
2. Bliss TV, Collingridge GL. (1993). A synaptic model of memory: longterm potentiation in the hippocampus. Nature 361:31-9.
3. Boucher HW, Talbot GH, Bradley JS, et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12.
4. Dai C, Li J, Lin W, et al. (2012). Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin sulfate exposure. Toxicol Mech Methods 22:592-6.
5. Docobo-Pe'rez F, Nordmann P, Domi'nguez-Herrera J, et al. (2012). Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Int J Antimicrob Agent 39:251-4.
6. Dorta DJ, Leite S, DeMarco KC, et al. (2003). A proposed sequence of events for cadmium-induced mitochondrial impairment. J Inorg Biochem 97:251-7.
7. Evans ME, Feola DJ, Rapp RP. (1999). Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 33:960-7.
8. Falagas ME, Kasiakou SK. (2005). Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333-41.
9. Falagas ME, Kasiakou SK. (2006). Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27.
10. Falagas ME, Michalopoulos A. (2006). Polymyxins: old antibiotics are back. Lancet Infect Dis 367:633-4.
11. Giacomello M, Drago I, Pizzo P, Pozzan T. (2007). Mitochondrial Ca2 as a key regulator of cell life and death. Cell Death Differ 14:1267-74.
12. Jin L, Li J, Nation RL, Nicolazzo JA. (2009). Brain penetration of colistin in mice assessed by a novel high-performance liquid
13. Azzopardi EA, Ferguson EL, Thomas DW. (2012). Colistin past and future: a bibliographic analysis. J Crit Care Jul 2 [Epub ahead of print]. doi: 10.1016/j.jcrc.2012.04.008.
14. Bliss TV, Collingridge GL. (1993). A synaptic model of memory: longterm potentiation in the hippocampus. Nature 361:31-9.
15. Boucher HW, Talbot GH, Bradley JS, et al. (2009). Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis 48:1-12.
16. Dai C, Li J, Lin W, et al. (2012). Electrophysiology and ultrastructural changes in mouse sciatic nerve associated with colistin sulfate exposure. Toxicol Mech Methods 22:592-6.
17. Docobo-Pe'rez F, Nordmann P, Domi'nguez-Herrera J, et al. (2012). Efficacies of colistin and tigecycline in mice with experimental pneumonia due to NDM-1-producing strains of Klebsiella pneumoniae and Escherichia coli. Int J Antimicrob Agent 39:251-4.
18. Dorta DJ, Leite S, DeMarco KC, et al. (2003). A proposed sequence of events for cadmium-induced mitochondrial impairment. J Inorg Biochem 97:251-7.
19. Evans ME, Feola DJ, Rapp RP. (1999). Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann Pharmacother 33:960-7.
20. Falagas ME, Kasiakou SK. (2005). Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. Clin Infect Dis 40:1333-41.
21. Falagas ME, Kasiakou SK. (2006). Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care 10:R27.
22. Falagas ME, Michalopoulos A. (2006). Polymyxins: old antibiotics are back. Lancet Infect Dis 367:633-4.
23. Giacomello M, Drago I, Pizzo P, Pozzan T. (2007). Mitochondrial Ca2 as a key regulator of cell life and death. Cell Death Differ 14:1267-74.
24. Jin L, Li J, Nation RL, Nicolazzo JA. (2009). Brain penetration of colistin in mice assessed by a novel high-performance liquid chromatographic technique. Antimicrob Agents Chemother 53:4247-51.
25. Jin L, Li J, Nation RL, Nicolazzo JA. (2011). Impact of p-glycoprotein inhibition and lipopolysaccharide administration on blood-brain barrier transport of colistin in mice. Antimicrob Agents Chemother 55:502-7.
26. Jin L, Li J, Nation RL, Nicolazzo JA. (2012). Effect of systemic infection induced by pseudomonas aeruginosa on the brain uptake of colistin in mice. Antimicrob Agents Chemother 56:5240-6.
27. Kim BN, Peleg AY, Lodise TP, et al. (2009). Management of meningitis due to antibiotic-resistant Acinetobacter species. Lancet Infect Dis 9:245-55.
28. Koh CH, Cheung NS. (2006). Cellular mechanism of U18666Amediated apoptosis in cultured murine cortical neurons: bridging Niemann-Pick disease type C and Alzheimer's disease. Cell Signal 18:1844-53.
29. Kucers A, Crowe S, Grayson ML, Hoy J. (1997). Polymyxins, In Kucers A, Crowe S, Grayson ML, Hoy J, eds. The use of antibiotics. 5th ed. Oxford: Butterworth-Heinemann, 667-75.
30. Landman WJ, Dwars RM, Keukens HJ, Berendsen BJ. (2000). Polymyxin E-1 (colistin sulphate) (neuro-) intoxication in young ostriches (Struthio camelus spp). Avian Pathol 29:593-601.
31. Lim LM, Ly N, Anderson D, et al. (2010). Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 30: 1279-91.
32. Lin B, Zhang C, Xiao X. (2005). Toxicity, bioavailability and pharmacokinetics of a newly formulated colistin sulfate solution. J Vet Pharmacol Ther 28:349-54.
33. Livak KJ, Schmittgen TD. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-8.
34. Lopachin RM, Lehning EJ. (1997). Mechanism of calcium entry during axon injury and degeneration. Toxicol Appl Pharmacol 143:233-44.
35. McCandless DW. (1985). Octanoic acid-induced coma and reticular formation energy metabolism. Brain Res 335:131-7.
36. Melli G, Taiana M, Camozzi F, et al. (2008). Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy. Exp Neurol 214:276-84.
37. Me'ndez-Armenta M., Ri'os C. (2007). Cadmium neurotoxicity. Environ Toxicol Pharmacol 23:350-8.
38. Molina J, Cordero E, Pachon J. (2009). New information about the polymyxin/colistin class of antibiotics. Expert Opin Pharmacother 10:2811-28.
39. Owen RJ, Li J, Nation RL, Spelman D. (2007). In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates. J Antimicrob Chemother 59:473-7.
40. Ozyilmaz E, Ebinc FA, Derici U, et al. (2011). Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine? Intensive Care Med 37:141-6.
41. Poudyal A, Howden BP, Bell JM, et al. (2008). In vitro pharmacodynamics of colistin against multidrug-resistant Klebsiella pneumoniae. J Antimicrob Chemother 62:1311-18.
42. Teter SA, Klionsky DJ. (2000). Transport of proteins to the yeast vacuole: autophagy, cytoplasm-to-vacuole targeting, and role of the vacuole in degradation. Semin Cell Dev Biol 11:173-9.
43. Toscano CD, Guilarte TR. (2005). Lead neurotoxicity: from exposure to molecular effects. Brain Res Rev 49:529-54.
44. Vanhaeverbeek M, Ectors M, Vanhaelst L, Franken L. (1974). Myopathy caused by polymixin E: functional disorder of the cell membrane. J Neurol Neurosurg Psych 37:1343-5.
45. Wabhy K, Chopra T, Chandrasekar P. (2010). Intravenous and inhalational colistin-induced respiratory failure. Clin Infect Dis 50:e38-40.
46. Wallace SJ, Li J, Nation RL, et al. (2008). Subacute toxicity of colistin methanesulfonate in rats: comparison of various intravenous dosage regimens. Antimicrob Agents Chemother 52:1159-61.
47. Weydt P, Pineda VV, Torrence AE, et al. (2006). Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration. Cell Metab 4:349-62.
48. Xia Z, Storm DR. (2005). The role of calmodulin as a signal integrator for synaptic plasticity. Nat Rev Neurosci 6:267-76.
49. Yoo ID, Yun B, Ryoo IJ, et al. (2002). Complestatin antagonizes the AMPA/kainate-induced neurotoxicity in cultured chick telencephalic neurons. Neurochem Res 27:337-43.
50. Yousef JM, Chen G, Hill PA, et al. (2012). Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother 67:452-9.
51. Yue Z. (2007). Regulation of neuronal autophagy in axon: implication of autophagy in axonal function and dysfunction/degeneration. Autophagy 3:139-41.